Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis: Results from a multicenter, randomized study

P. Mandl, P. Bálint, Y. Brault, M. Backhaus, M. A. D'Agostino, W. Grassi, D. Van Der Heijde, E. De Miguel, R. J. Wakefield, I. Logeart, M. Dougados

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: To evaluate the metrologic properties of composite disease activity indices in rheumatoid arthritis (RA), utilizing information derived from clinical, gray-scale (GS), and power Doppler (PD) ultrasound examinations, and to assess the classification of patients according to disease activity using such indices. Methods This ancillary study utilized data from a multicenter, prospective, randomized, parallel-group study conducted in subjects with moderate RA randomized to receive etanercept and methotrexate (ETN + MTX) or usual care (various disease-modifying antirheumatic drugs [DMARDs]). In multimodal indices, the 28 swollen joint count was either supplemented or replaced by clinically nonswollen joints in which the presence of synovitis was detected either by GS and/or PD and was calculated according to the Disease Activity Score in 28 joints (DAS28) or the Simplified Disease Activity Index (SDAI). Reliability, external validity, and discriminative capacity were calculated at baseline/screening by intraclass correlation coefficient, Pearson's correlation, and standardized response mean, respectively. Results: Data from 62 patients (mean ± SD age 53.8 ± 13.2 years, mean ± SD disease duration 8.8 ± 7.7 years, mean ± SD disease activity 4.6 ± 0.5 [DAS28] and 20.9 ± 5.9 [SDAI]) were analyzed, with 32 receiving ETN + MTX and 30 receiving DMARDs. The metrologic properties were at least as good for GS- and/or PD-based indices as for their clinical counterparts. Using GS- and PD-supplemented indices, an additional 67.8% and 32.3% of patients (DAS28-derived and SDAI-derived indices, respectively) could be classified as having high disease activity at the screening visit. Conclusion: Multimodal indices incorporating ultrasound and clinical data had similar metrologic properties to their clinical counterparts; certain indices allowed for a significantly larger number of patients to be classified to either high or moderate disease activity at the screening visit.

Original languageEnglish
Pages (from-to)879-887
Number of pages9
JournalArthritis Care and Research
Volume65
Issue number6
DOIs
Publication statusPublished - 2013

Fingerprint

Multicenter Studies
Rheumatoid Arthritis
Joints
Antirheumatic Agents
Doppler Ultrasonography
Synovitis
Reproducibility of Results
Methotrexate

ASJC Scopus subject areas

  • Rheumatology

Cite this

Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis : Results from a multicenter, randomized study. / Mandl, P.; Bálint, P.; Brault, Y.; Backhaus, M.; D'Agostino, M. A.; Grassi, W.; Van Der Heijde, D.; De Miguel, E.; Wakefield, R. J.; Logeart, I.; Dougados, M.

In: Arthritis Care and Research, Vol. 65, No. 6, 2013, p. 879-887.

Research output: Contribution to journalArticle

Mandl, P, Bálint, P, Brault, Y, Backhaus, M, D'Agostino, MA, Grassi, W, Van Der Heijde, D, De Miguel, E, Wakefield, RJ, Logeart, I & Dougados, M 2013, 'Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis: Results from a multicenter, randomized study', Arthritis Care and Research, vol. 65, no. 6, pp. 879-887. https://doi.org/10.1002/acr.21913
Mandl, P. ; Bálint, P. ; Brault, Y. ; Backhaus, M. ; D'Agostino, M. A. ; Grassi, W. ; Van Der Heijde, D. ; De Miguel, E. ; Wakefield, R. J. ; Logeart, I. ; Dougados, M. / Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis : Results from a multicenter, randomized study. In: Arthritis Care and Research. 2013 ; Vol. 65, No. 6. pp. 879-887.
@article{54a40598300f4fae80eb0928e874da65,
title = "Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis: Results from a multicenter, randomized study",
abstract = "Objective: To evaluate the metrologic properties of composite disease activity indices in rheumatoid arthritis (RA), utilizing information derived from clinical, gray-scale (GS), and power Doppler (PD) ultrasound examinations, and to assess the classification of patients according to disease activity using such indices. Methods This ancillary study utilized data from a multicenter, prospective, randomized, parallel-group study conducted in subjects with moderate RA randomized to receive etanercept and methotrexate (ETN + MTX) or usual care (various disease-modifying antirheumatic drugs [DMARDs]). In multimodal indices, the 28 swollen joint count was either supplemented or replaced by clinically nonswollen joints in which the presence of synovitis was detected either by GS and/or PD and was calculated according to the Disease Activity Score in 28 joints (DAS28) or the Simplified Disease Activity Index (SDAI). Reliability, external validity, and discriminative capacity were calculated at baseline/screening by intraclass correlation coefficient, Pearson's correlation, and standardized response mean, respectively. Results: Data from 62 patients (mean ± SD age 53.8 ± 13.2 years, mean ± SD disease duration 8.8 ± 7.7 years, mean ± SD disease activity 4.6 ± 0.5 [DAS28] and 20.9 ± 5.9 [SDAI]) were analyzed, with 32 receiving ETN + MTX and 30 receiving DMARDs. The metrologic properties were at least as good for GS- and/or PD-based indices as for their clinical counterparts. Using GS- and PD-supplemented indices, an additional 67.8{\%} and 32.3{\%} of patients (DAS28-derived and SDAI-derived indices, respectively) could be classified as having high disease activity at the screening visit. Conclusion: Multimodal indices incorporating ultrasound and clinical data had similar metrologic properties to their clinical counterparts; certain indices allowed for a significantly larger number of patients to be classified to either high or moderate disease activity at the screening visit.",
author = "P. Mandl and P. B{\'a}lint and Y. Brault and M. Backhaus and D'Agostino, {M. A.} and W. Grassi and {Van Der Heijde}, D. and {De Miguel}, E. and Wakefield, {R. J.} and I. Logeart and M. Dougados",
year = "2013",
doi = "10.1002/acr.21913",
language = "English",
volume = "65",
pages = "879--887",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Clinical and ultrasound-based composite disease activity indices in rheumatoid arthritis

T2 - Results from a multicenter, randomized study

AU - Mandl, P.

AU - Bálint, P.

AU - Brault, Y.

AU - Backhaus, M.

AU - D'Agostino, M. A.

AU - Grassi, W.

AU - Van Der Heijde, D.

AU - De Miguel, E.

AU - Wakefield, R. J.

AU - Logeart, I.

AU - Dougados, M.

PY - 2013

Y1 - 2013

N2 - Objective: To evaluate the metrologic properties of composite disease activity indices in rheumatoid arthritis (RA), utilizing information derived from clinical, gray-scale (GS), and power Doppler (PD) ultrasound examinations, and to assess the classification of patients according to disease activity using such indices. Methods This ancillary study utilized data from a multicenter, prospective, randomized, parallel-group study conducted in subjects with moderate RA randomized to receive etanercept and methotrexate (ETN + MTX) or usual care (various disease-modifying antirheumatic drugs [DMARDs]). In multimodal indices, the 28 swollen joint count was either supplemented or replaced by clinically nonswollen joints in which the presence of synovitis was detected either by GS and/or PD and was calculated according to the Disease Activity Score in 28 joints (DAS28) or the Simplified Disease Activity Index (SDAI). Reliability, external validity, and discriminative capacity were calculated at baseline/screening by intraclass correlation coefficient, Pearson's correlation, and standardized response mean, respectively. Results: Data from 62 patients (mean ± SD age 53.8 ± 13.2 years, mean ± SD disease duration 8.8 ± 7.7 years, mean ± SD disease activity 4.6 ± 0.5 [DAS28] and 20.9 ± 5.9 [SDAI]) were analyzed, with 32 receiving ETN + MTX and 30 receiving DMARDs. The metrologic properties were at least as good for GS- and/or PD-based indices as for their clinical counterparts. Using GS- and PD-supplemented indices, an additional 67.8% and 32.3% of patients (DAS28-derived and SDAI-derived indices, respectively) could be classified as having high disease activity at the screening visit. Conclusion: Multimodal indices incorporating ultrasound and clinical data had similar metrologic properties to their clinical counterparts; certain indices allowed for a significantly larger number of patients to be classified to either high or moderate disease activity at the screening visit.

AB - Objective: To evaluate the metrologic properties of composite disease activity indices in rheumatoid arthritis (RA), utilizing information derived from clinical, gray-scale (GS), and power Doppler (PD) ultrasound examinations, and to assess the classification of patients according to disease activity using such indices. Methods This ancillary study utilized data from a multicenter, prospective, randomized, parallel-group study conducted in subjects with moderate RA randomized to receive etanercept and methotrexate (ETN + MTX) or usual care (various disease-modifying antirheumatic drugs [DMARDs]). In multimodal indices, the 28 swollen joint count was either supplemented or replaced by clinically nonswollen joints in which the presence of synovitis was detected either by GS and/or PD and was calculated according to the Disease Activity Score in 28 joints (DAS28) or the Simplified Disease Activity Index (SDAI). Reliability, external validity, and discriminative capacity were calculated at baseline/screening by intraclass correlation coefficient, Pearson's correlation, and standardized response mean, respectively. Results: Data from 62 patients (mean ± SD age 53.8 ± 13.2 years, mean ± SD disease duration 8.8 ± 7.7 years, mean ± SD disease activity 4.6 ± 0.5 [DAS28] and 20.9 ± 5.9 [SDAI]) were analyzed, with 32 receiving ETN + MTX and 30 receiving DMARDs. The metrologic properties were at least as good for GS- and/or PD-based indices as for their clinical counterparts. Using GS- and PD-supplemented indices, an additional 67.8% and 32.3% of patients (DAS28-derived and SDAI-derived indices, respectively) could be classified as having high disease activity at the screening visit. Conclusion: Multimodal indices incorporating ultrasound and clinical data had similar metrologic properties to their clinical counterparts; certain indices allowed for a significantly larger number of patients to be classified to either high or moderate disease activity at the screening visit.

UR - http://www.scopus.com/inward/record.url?scp=84878570328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878570328&partnerID=8YFLogxK

U2 - 10.1002/acr.21913

DO - 10.1002/acr.21913

M3 - Article

C2 - 23213004

AN - SCOPUS:84878570328

VL - 65

SP - 879

EP - 887

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 6

ER -